Who Owns Aprea Therapeutics Stock?
NASDAQ: APREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 18.83%
- Held by insiders
- 9.17%
- Institutional holders
- 32
- Institutions 18.8%
- Insiders 9.2%
- Public and other 72.0%
Who owns Aprea Therapeutics stock?
Institutional investors own about 18.8% of Aprea Therapeutics's shares, spread across 32 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 9.17% of APRE.
The largest institutional holders are AIGH Capital Management LLC (8.07%), Vestal Point Capital, LP (2.78%) and Sphera Funds Management Ltd. (2.14%). Together, the top 10 institutions control 17.5% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their APRE positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of APRE
| Institution | Shares | % Held | Change |
|---|---|---|---|
| AIGH Capital Management LLC | 1.02M | 8.07% | 0.0% |
| Vestal Point Capital, LP | 350.00K | 2.78% | 0.0% |
| Sphera Funds Management Ltd. | 270.00K | 2.14% | 0.0% |
| Nantahala Capital Management, LLC | 205.76K | 1.63% | 0.0% |
| Renaissance Technologies, LLC | 105.80K | 0.84% | +321.5% |
| Geode Capital Management, LLC | 74.87K | 0.59% | -37.1% |
| Citadel Advisors Llc | 58.60K | 0.47% | +100.0% |
| BNP Paribas Financial Markets | 45.21K | 0.36% | +13.6% |
| Diadema Partners LP | 44.91K | 0.36% | +100.0% |
| Vanguard Fiduciary Trust Co | 38.46K | 0.31% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of APRE
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 59.94K | 0.48% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 19.62K | 0.16% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 7.20K | 0.06% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 5.85K | 0.05% |
| Master Investment Portfolio-Diversified Equity Alpha Master Portfolio | 289 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Aprea Therapeutics?
AIGH Capital Management LLC is the largest institutional shareholder of APRE, owning 8.07% of shares outstanding (1.02M shares) as of its latest 13F filing.
What percentage of Aprea Therapeutics is owned by institutions?
Institutions own about 18.8% of APRE shares and 20.7% of the public float.
How much of Aprea Therapeutics do insiders own?
Insiders, such as officers and directors, own about 9.17% of APRE shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.